Healthcare -
Biotechnology - NASDAQ - US
$ 20.285
-1.96 %
$ 15 B
Market Cap
-65.44
P/E
SMMT - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity SMMT - Summit Therapeutics Inc.
203 M
LAST VALUE
33.79%
2 YEAR CAGR
20.96%
5 YEAR CAGR
33.92%
10 YEAR CAGR